Cargando…

Effect of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of dolasetron and granisetron

OBJECTIVE: The objective of this study was to characterize the impact of casopitant, a novel neurokinin-1 receptor antagonist under investigation for the prevention of postoperative and chemotherapy-induced nausea and vomiting, on the pharmacokinetics of the commonly prescribed 5-hydroxytryptamine r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adams, Laurel M., Johnson, Brendan, Zhang, Ke, Yue, Lin, Kirby, Lyndon C., Lebowitz, Peter, Stoltz, Randall
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2009
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726911/ https://www.ncbi.nlm.nih.gov/pubmed/19205754 http://dx.doi.org/10.1007/s00520-008-0572-4

Ejemplares similares

Impact of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of ondansetron and dexamethasone
por: Johnson, Brendan, et al.
Publicado: (2009)

Casopitant: a novel NK(1)-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting
por: Ruhlmann, Christina, et al.
Publicado: (2009)

Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV)
por: Schwartzberg, Lee, et al.
Publicado: (2013)

Reappraisal of the role of dolasetron in prevention and treatment of nausea and vomiting associated with surgery or chemotherapy
por: Roberts, S Michael, et al.
Publicado: (2012)

Reappraisal of the role of dolasetron in prevention and treatment of nausea and vomiting associated with surgery or chemotherapy [Erratum]
Publicado: (2016)

CdS nanocrystals as fluorescent probe for detection of dolasetron mesylate in aqueous solution: Application to biomedical analysis()
por: Pawar, Samadhan P., et al.
Publicado: (2016)

Population pharmacokinetic analysis of transdermal granisetron in healthy Chinese and Caucasian volunteers
por: Li, Jiayu, et al.
Publicado: (2023)

Comparison of granisetron alone and granisetron plus dexamethasone in the prophylaxis of cytotoxic-induced emesis.
por: Carmichael, J., et al.
Publicado: (1994)

Dose finding study of granisetron in patients receiving high-dose cisplatin chemotherapy. The Granisetron Study Group.
por: Riviere, A.
Publicado: (1994)

Enhanced Transdermal Delivery of Granisetron by Using Iontophoresis
por: Panzade, Prabhakar, et al.
Publicado: (2012)

Symptomatic Improvement of Gastroparesis with Granisetron Transdermal System
por: Jung, Hye-Kyung
Publicado: (2016)

Postoperative nausea and vomiting prophylaxis: A comparative study of ondansetron, granisetron and granisetron and dexamethasone combination after modified radical mastectomy
por: Gupta, Pushplata, et al.
Publicado: (2014)

Granisetron versus Granisetron-Dexamethasone for Prevention of Postoperative Nausea and Vomiting in Pediatric Strabismus Surgery: A Randomized Double-Blind Trial
por: Sinha, Renu, et al.
Publicado: (2016)

Inducing Cytotoxicity in Colon Cancer Cells and Suppressing Cancer Stem Cells by Dolasetron and Ketoprofen through Inhibition of RNA Binding Protein PUM1
por: Gor, Ravi, et al.
Publicado: (2023)

Granisetron versus Ondansetron: Comparison of 5HT(3) antagonists in preventing spinal anaesthesia induced hemodynamic instability in obstetric patients
por: Wahid, Maheen, et al.
Publicado: (2022)

Comparison the Effect of Granisetron and Dexamethasone on Intravenous Propofol Pain
por: Adinehmehr, Leili, et al.
Publicado: (2018)

Granisetron plus aprepitant versus granisetron in preventing nausea and vomiting during CHOP or R-CHOP regimen in malignant lymphoma: a retrospective study
por: Wakasugi, Yoshinori, et al.
Publicado: (2019)

Influence of Polymorphisms in the HTR3A and HTR3B Genes on Experimental Pain and the Effect of the 5-HT(3) Antagonist Granisetron
por: Louca Jounger, Sofia, et al.
Publicado: (2016)

The control of acute cisplatin-induced emesis--a comparative study of granisetron and a combination regimen of high-dose metoclopramide and dexamethasone. Granisetron Study Group.
por: Chevallier, B.
Publicado: (1993)

Influence of serotonin on the analgesic effect of granisetron on temporomandibular joint arthritis.
por: Voog, Ulle, et al.
Publicado: (2004)

Carbon monoxide contributes to the constipating effects of granisetron in rat colon
por: Nacci, Carmela, et al.
Publicado: (2016)

Domperidone/granisetron/metoclopramide: Long QT syndrome: case report
Publicado: (2022)

Safety, Pharmacokinetics, and Pharmacodynamics of Trazpiroben (TAK‐906), a Novel Selective D(2)/D(3) Receptor Antagonist: A Phase 1 Randomized, Placebo‐Controlled Single‐ and Multiple‐Dose Escalation Study in Healthy Participants
por: Whiting, Roger L., et al.
Publicado: (2021)

Use and cardiovascular safety of transdermal and other granisetron preparations in cancer management
por: Mason, Jay W, et al.
Publicado: (2013)

Granisetron Versus Dexamethasone in Prophylaxis of Nausea and Vomiting After Laparoscopic Cholecystectomy
por: Hessami, Mohammad Ali, et al.
Publicado: (2012)

Development and Validation of RP-HPLC Method for Simultaneous Determination of Granisetron and Dexamethasone
por: Heda, A. A., et al.
Publicado: (2011)

Ramosetron compared with granisetron for the prevention of vomiting following strabismus surgery in children
por: Fujiia, Yoshitaka, et al.
Publicado: (2016)

Pharmacokinetics, safety, and efficacy of APF530 (extended-release granisetron) in patients receiving moderately or highly emetogenic chemotherapy: results of two Phase II trials
por: Gabrail, Nashat, et al.
Publicado: (2015)

The incidence of anticipatory nausea and vomiting after repeat cycle chemotherapy: the effect of granisetron.
por: Aapro, M. S., et al.
Publicado: (1994)

Granisetron versus tropisetron in the prevention of postoperative nausea and vomiting after total thyroidectomy
por: Papadima, Artemisia, et al.
Publicado: (2013)

Paracetamol, Ondansetron, Granisetron, Magnesium Sulfate and Lidocaine and Reduced Propofol Injection Pain
por: Alipour, Mohammad, et al.
Publicado: (2014)

Biochronomer™ technology and the development of APF530, a sustained release formulation of granisetron
por: Ottoboni, Thomas, et al.
Publicado: (2014)

Granisetron Transdermal System for Treatment of Symptoms of Gastroparesis: A Prescription Registry Study
por: Midani, Deena, et al.
Publicado: (2016)

Hemin and Zinc Protoporphyrin IX Affect Granisetron Constipating Effects In Vitro and In Vivo
por: Zigrino, Addolorata, et al.
Publicado: (2013)

Extended release granisetron: Review of pharmacologic considerations and clinical role in the perioperative setting
por: Ngo, Anh L., et al.
Publicado: (2019)

Comparison of Ondansetron and Granisetron Effects for Prevention of Nausea and Vomiting Following Strabismus Surgery
por: Salajegheh, Shirin, et al.
Publicado: (2019)

Pharmacokinetics and safety of TCMCB07, a melanocortin‐4 antagonist peptide in dogs
por: Axiak‐Bechtel, Sandra M., et al.
Publicado: (2021)

Development of novel bioadhesive granisetron hydrochloride spanlastic gel and insert for brain targeting and study their effects on rats
por: Abdelmonem, Rehab, et al.
Publicado: (2017)

Prophylactic Granisetron Vs Pethidine for the Prevention of Postoperative Shivering: A Randomized Control Trial
por: Iqbal, Asif, et al.
Publicado: (2009)

Use of granisetron transdermal system in the prevention of chemotherapy-induced nausea and vomiting: a review
por: Tuca, Albert
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_pqpn5v0c1p3ld1npq1sq97lm5v